Court rejects Healthscope
Tuesday, 02 September, 2008
The NSW Supreme Court has rejected Healthscope's [ASX: HSP] appeal for a break free from Symbion Health.
Healthscope, a private hospital operator which also owns some pathology businesses, had argued that pathology specialist Symbion should pay the company $19.5 million after reneging on a deal which would have seen Healthscope acquire Symbion's diagnostics business.
The court ordered that the break fee was not required. Healthscope is planning to lodge an appeal with the NSW Court of Appeal.
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
Gene therapy slows Huntington's disease progression in trial
Patients receiving the treatment were found to experience 75% less progression of the disease...
AI-driven manufacturing: lessons from the life sciences industry
The use of artificial intelligence for batch monitoring and digital twin development is...
